Clinical Features and Pathogenesis of Catastrophic Antiphospholipid Syndrome

Internal Medicine

Volumn 39, Issue 10, 2000, Pages 763-764

  Kaburaki, Junichi ^a  

^a TOKYO ELECTRIC POWER COMPANY   (Japan)

Author keywords

antiphospholipid antibodies; thrombocytopenia; thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; HUMAN; IMMUNOLOGY; NOTE; SYSTEMIC LUPUS ERYTHEMATOSUS; TERMINAL DISEASE;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0034303177     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.763     Document Type: Article

References (15)

1. Harris EN. Antiphospholipid antibodies. Br J Haematol 74: 1–9, 1990.
2. McNeil HP, Simpson RJ, Chesterman C, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipidbinding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci, USA 87: 4120–4124, 1990.
3. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 1544–1547, 1990.
4. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336: 177–178, 1990 (letter).
5. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF. Lupus anticoagulant IgG’s (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 66: 629–632, 1991.
6. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 19: 508–512, 1992 (editorial).
7. Asherson RA, Cervera R, Piette J-C, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77:195-207, 1998.
8. Asherson RA. The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment. Lupus 7 Suppl 2: S55-S62, 1998.
9. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine (Baltimore) 45: 139—159, 1966.
10. Mizuno R, Fujimoto S, Fujimoto T, et al. Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman. Intern Med 39: 856–859, 2000.
11. Golden BD, Belmont HM. The role of microvasculopathy in the catastrophic antiphospholipid syndrome: comment on the article by Neuwelt et al. Arthritis Rheum 41: 751–753, 1998 (letter).
12. Trent K, Neustater BR, Lottenberg R. Chronic relapsing thrombotic thrombocytopenic purpura and antiphospholipid antibodies: A report of two cases. Am J Haematol 54: 155–159, 1997.
13. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticure-mic syndrome. N Engl J Med 339: 1578-1584,1998.
14. Tsai H-M, Lian EC-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339: 1585–1594, 1998.
15. Hess DC, Sethi K, Awad E. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: Effective treatment with plasma exchange and immunosuppression. J Rheumatol 19: 1474–1478, 1992.